Concepedia

Rex Wan Hin Hui

RW

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2022

Affiliations

Queen Mary Hospital(Current)

University of Hong Kong

Rex Wan Hin Hui is an author at Queen Mary Hospital specializing in steatosis quantification, hepatic steatosis assessment, and coronavirus vaccines.

Publications per year

2022–2025

3

Publications

3

Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial

Ka Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui et al. · Hepatology · 2024 · 41 citations

, , +17

Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients

Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui et al. · Clinical and Molecular Hepatology · 2022 · 19 citations · Full text

, , +17

Gut Microbiota Predicts Treatment Response to Empagliflozin Among <scp>MASLD</scp> Patients Without Diabetes Mellitus

Ho Yu Ng, Lina Zhang, Jing Tong Tan et al. · Liver International · 2025 · 12 citations · Full text

, , +17

1–3 of 3